Chemoradiotherapy plus tislelizumab for mismatch repair proficient rectal cancer with supraclavicular lymph node metastasis: A case report

doi:10.4251/wjgo.v16.i5.2219

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (672)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

HTML

435

Figures (1-3)

Sum=524

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=122

May 15, 2024 (publication date) through Jul 25, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastrointest Oncol. May 15, 2024; 16(5): 2219-2224
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.2219

Full Size Figure Download Figure

Figure 3 Immunohistochemical staining of CD8+ T cell and effector regulatory T cell before and after treatment. A: CD8+ T cell in tumor cells before treatment; B: effector regulatory T cell (eTreg) in tumor cells before treatment; C: CD8+ T cell in tumor cells after treatment; D: eTreg in tumor cells after treatment.

Citation: Zhong WT, Lv Y, Wang QY, An R, Chen G, Du JF. Chemoradiotherapy plus tislelizumab for mismatch repair proficient rectal cancer with supraclavicular lymph node metastasis: A case report. World J Gastrointest Oncol 2024; 16(5): 2219-2224
URL: https://www.wjgnet.com/1948-5204/full/v16/i5/2219.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i5.2219